Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of cervical cancer (squamous carcinoma, adenocarcinoma, or squamous adenocarcinoma) at an early stage (Stage IB1, IB2, or IIA1)
- People aged 21 to 70 years old
- People whose planned surgery falls under a specific surgical classification known as Type B or C (the trial site can confirm what this means for an individual case)
- People whose blood test results fall within acceptable ranges, including healthy enough levels of red blood cells, platelets, white blood cells, kidney function markers, and liver function markers
- People with no history of any other type of cancer
- People who are not pregnant
- People who have a physical fitness score of at least 60 on the Karnofsky scale, meaning they are reasonably able to carry out daily activities (the trial site can assess this)
- People who are willing to take part, sign a consent form, and attend follow-up appointments
- People who do not have a psychiatric disorder or a serious immune system condition such as lupus, myasthenia gravis, or HIV
Who may not be able to join:
- People who have a medical reason that prevents them from having surgery
- People who have previously received radiotherapy to the pelvis or abdomen, or chemotherapy given before surgery, for cervical cancer
- People whose cervical cancer has come back after previous treatment
- People whose scans (CT, MRI, or PET-CT) show signs of possible cancer spread to pelvic lymph nodes larger than 2cm in size
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xin Wu, PHD, The Obstetrics and Gynecology Hospital of Fudan University
Phone: (021)33189900-6529
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the rate of PFS at 5 years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.